Showing results (851-860 of 936) with videos related to

Sort By:
Pageof 94
European Journal of Pediatrics|July 30, 2014
Associations of early life and sociodemographic factors with menarcheal age in European adolescentsEvelien Meulenijzer, Krishna Vyncke, Idoia Labayen, et al.
Nature Medicine|September 30, 2021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionShuo Feng, Daniel J Phillips, Thomas White, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 15, 2013
Intake and serum profile of fatty acids are weakly correlated with global dietary quality in European adolescentsKrishna E Vyncke, Inge Huybrechts, Jean Dallongeville, et al.
ESMO Open|July 11, 2022
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)S Rao, G Anandappa, J Capdevila, et al.
The British Journal of Nutrition|February 29, 2012
Dietary fatty acid intake, its food sources and determinants in European adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) StudyKrishna E Vyncke, Lars Libuda, Tineke De Vriendt, et al.
Infection and Immunity|August 18, 2010
New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1Anna L Goodman, C Epp, D Moss, et al.
Human Vaccines & Immunotherapeutics|November 13, 2012
Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trialRosalind Rowland, Ansar A Pathan, Iman Satti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2012
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humansPatrick J Lillie, Tamara K Berthoud, Timothy J Powell, et al.
Nature Communications|October 8, 2021
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7Robert J Fischer, Neeltje van Doremalen, Danielle R Adney, et al.
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Pageof 94